Nuvectis Pharma Inc. (NVCT) Social Stream
NUVECTIS PHARMA INC (NVCT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NUVECTIS PHARMA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-13 | 1 | $14 | $14 | $14 | $9.73 | 43.88% |
| 2022-04-17 | 2 | $20 | $14 | $17 | $9.73 | 74.72% |
| 2022-06-13 | 2 | $21 | $20 | $20.5 | $9.73 | 110.69% |
| 2023-03-07 | 2 | $21 | $20 | $20.666 | $9.73 | 112.39% |
| 2023-11-09 | 3 | $21 | $20 | $20.666 | $9.73 | 112.39% |
| NA | 1 | $NA | $NA | $NA | $9.73 | NA% |
The Trend in the Analyst Price Target
Over the past 178 days, NVCT's average price target has gone down $0.
NVCT reports an average of 65.91% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-10 | 3 | 21 | 20 | 20.666 | 14.37 | 43.81% |
| 2023-02-10 | 2 | 21 | 20 | 20.666 | 14.37 | 43.81% |
| 2023-03-07 | 2 | 21 | 20 | 20.666 | 11.34 | 82.24% |
| 2023-08-09 | 3 | 21 | 20 | 20.666 | 14.94 | 38.33% |
| 2023-11-09 | 3 | 21 | 20 | 20.666 | 8.23 | 151.11% |
NVCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 20 months, NVCT's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, NUVECTIS PHARMA INC's number of analysts covering the stock is greater than 18.63% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NUVECTIS PHARMA INC's variance in analysts' estimates is lower than 67.22% of them.
- In the context of stocks in the micro market cap category, NUVECTIS PHARMA INC's average analyst price target is higher than 424.5% of them.
- In the context of stocks in the micro market cap category, NUVECTIS PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 203.65% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NUVECTIS PHARMA INC are ACRV, COYA, and SMFL.
View All Top Stocks by Price Target
What is the outlook for NVCT? Use POWR Ratings for clearer insight into price direction.